Literature DB >> 34226298

Bioinformatics analysis for the identification of key genes and long non-coding RNAs related to bone metastasis in breast cancer.

Xu Teng1, Tianshu Yang1, Wei Huang1, Weishi Li2, Lin Zhou3, Zihang Wang3, Yajuan Feng3, Jingyao Zhang4, Xin Yin1, Pei Wang1, Gen Li1, Hefeng Yu1, Zhongqiang Chen2, Dongwei Fan2.   

Abstract

The molecular mechanism of bone metastasis in breast cancer is largely unknown. Herein, we aimed to identify the key genes and long non-coding RNAs (lncRNAs) related to the bone metastasis of breast cancer using a bioinformatics approach. We screened differentially expressed genes and lncRNAs between normal breast and breast cancer bone metastasis samples using the GSE66206 dataset from the Gene Expression Omnibus. We also constructed a differentially expressed lncRNA-mRNA interaction network and analyzed the node degrees to identify the driving genes. After finding potential pathogenic modules of breast cancer bone metastasis, we identified breast cancer bone metastasis-related modules and functional enrichment analysis of the genes and lncRNAs in the modules. Based on the above analysis, we constructed a differentially expressed lncRNA-mRNA network related to bone metastasis in breast cancer and identified core driver genes, including BNIP3 and the lncRNA RP11-317-J19.1. The role of core driver genes and lncRNAs in the network implies their biological functions in regulating bone development and remodeling. Thus, targeting the core driver genes and lncRNAs in the network may be a promising therapeutic strategy to manage bone metastasis.

Entities:  

Keywords:  bone metastasis; breast cancer; disease-causing gene modules; lncRNA-mRNA network

Year:  2021        PMID: 34226298     DOI: 10.18632/aging.203211

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  3 in total

1.  Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma.

Authors:  Taoli Wang; Zhulin Wu; Shiguang Li; Zhong Chen; Yiqi Chen; Zhenjiang Yang
Journal:  Int J Gen Med       Date:  2022-09-11

2.  Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC).

Authors:  Jessica L S Zylla; Mariah M Hoffman; Simona Plesselova; Somshuvra Bhattacharya; Kristin Calar; Yohannes Afeworki; Pilar de la Puente; Etienne Z Gnimpieba; W Keith Miskimins; Shanta M Messerli
Journal:  Cancers (Basel)       Date:  2022-03-30       Impact factor: 6.639

3.  Identification of hub genes for early detection of bone metastasis in breast cancer.

Authors:  Zitong Zhao; Haoran Yang; Guangling Ji; Shanshan Su; Yuqi Fan; Minghao Wang; Shengli Gu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.